Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 9.749% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1ccsc1C(=O)C1CCCN(Cc2ccn[nH]2)C1
b. CCc1nonc1NC(=O)c1oc2cc(C)c(Cl)cc2c1C
c. CCC(C)(C)NC(=O)CN(C(=O)c1csnn1)c1ccccc1-c1ccccc1
Answer: c. CCC(C)(C)NC(=O)CN(C(=O)c1csnn1)c1ccccc1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)NC(=O)CN(C(=O)c1csnn1)c1ccccc1-c1ccccc1
CCC(C)(C)NC(=O)CN(C(=O)c1csnn1)c1ccccc1-c1ccccc1
N-[2-(2-methylbutan-2-ylamino)-2-oxoethyl]-N-(2-phenylphenyl)thiadiazole-4-carboxamide